Breaking News

WuXi AppTec Invests $120M in Integrated Biologics Center

Will provide biologics discovery, development, and clinical manufacturing services

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi AppTec began construction of a $120 million, 250,000-sq.-ft., integrated biologics center at its headquarters in Shanghai. The facility will provide integrated solutions for biologics discovery, development, and clinical manufacturing. It will be operational in 2017 and accommodate 800 scientists.   The biologics discovery center will use the OmniRat platform in collaboration with Open Monoclonal Technology, Inc., and in-house phage display libraries to help clients discover conventional ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters